FrancophonIA/ELRC3.0 huggingface dataset:
English: A Your dose delivery will take around 45 minutes to complete.
Slovenian: A Injiciranje odmerka bo trajalo približno 45 minut, preden bo dokončano.
English: The on-body injector contains three silver oxide batteries and includes an adhesive patch made from non-woven polyester tape single coated with a polyacrylate adhesive.
Slovenian: Injektor vsebuje tri baterije s srebrovim oksidom in ima lepljivo površino iz netkanega poliestrskega traku, enojno kritega s poliakrilatnim lepilom.
English: This leaflet was last revised in
Slovenian: Navodilo je bilo nazadnje revidirano dne .
English: The pharmacokinetics of pegfilgrastim were studied in 37 paediatric patients with sarcoma, who received 100 mcg/kg pegfilgrastim after the completion of VAdriaC/IE chemotherapy.
Slovenian: Farmakokinetiko pegfilgrastima so raziskali pri 37 pediatričnih bolnikih s sarkomom, ki so po dokončanju kemoterapije z VAdriaC/IE dobili 100 µg/kg pegfilgrastima.
English: What do I do if the on-body injector comes off before the full dose is delivered?
Slovenian: Kaj storiti, če injektor odstopi, preden ste dobili celoten odmerek?
English: What to do if you hear beeping or when you look at the status light and it is flashing red.
Slovenian: Kaj storiti, če zaslišite piskanje, ali če lučka stanja rdeče utripa, ko jo pogledate.
English: See also section 2.
Slovenian: Glejte tudi poglavje 2.
English: • Keep the on-body injector dry for the last 3 hours prior to the start of dose delivery.
Slovenian: • Injektor naj bo suh vsaj 3 ure pred začetkom injiciranja odmerka.
English: For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
Slovenian: Za vse morebitne nadaljnje informacije o tem zdravilu se lahko obrnete na predstavništvo imetnika dovoljenja za promet z zdravilom.
English: ** The concentration is 20 mg/mL if the PEG moiety is included.
Slovenian: ** Če je vključen še delež PEG, je koncentracija 20 mg/ml.
English: • If the status light is flashing red, you may not have received your full dose and you may need a replacement dose.
Slovenian: • Če lučka stanja rdeče utripa, morda niste prejeli celotnega odmerka in boste morda potrebovali nadomestni odmerek.
English: The on-body injector should be applied to intact, non-irritated skin on the back of the arm or abdomen.
Slovenian: Injektor je treba namestiti na nepoškodovano, nerazdraženo kožo na zadnji strani nadlakta ali na trebuhu.
English: • cutaneous vasculitis (inflammation of the blood vessels in the skin).
Slovenian: • kožni vaskulitis (vnetje krvnih žil v koži).
English: B After about 27 hours, your on-body injector will produce a series of beeps to let you know your dose delivery is about to begin.
Slovenian: B Po približno 27 urah bo injektor oddal zaporedje piskov; tako boste vedeli, da se bo injiciranje odmerka vsak čas začelo.
English: • the top of your thighs; and
Slovenian: • zgornji del stegen; in
English: This medicinal product should not be used to increase the dose of cytotoxic chemotherapy beyond established dosage regimens.
Slovenian: Tega zdravila ne smete uporabljati za zvečevanje odmerka citotoksične kemoterapije preko uveljavljenih shem odmerjanja.
English: • The expiry date printed on the label has passed the last day of the month shown.
Slovenian: • je že pretekel zadnji dan meseca, navedenega v datumu izteka roka uporabnosti, ki je natisnjen na nalepki.
English: Manufacturer Amgen NV Telecomlaan 5-7 1831 Diegem Belgium
Slovenian: Izdelovalec Amgen NV Telecomlaan 5-7 1831 Diegem Belgija
English: Plan to be in a place where you or your caregiver can appropriately monitor the on-body injector for Neulasta during the approximately 45 minute Neulasta delivery and for an hour after the delivery.
Slovenian: Načrtujte tako, da bosta s skrbnikom v prostoru, kjer bosta lahko ustrezno nadzirala injektor z zdravilom Neulasta med približno 45-minutnim injiciranjem zdravila Neulasta in še eno uro po injiciranju.
English: These could be symptoms of an uncommon (may affect up to 1 in 100 people) condition called “Capillary Leak Syndrome” which causes blood to leak from the small blood vessels into your body and needs urgent medical attention.
Slovenian: To so lahko simptomi občasne motnje (pojavi se lahko pri do 1 od 100 oseb), imenovane "sindrom kapilarne prepustnosti", ki povzroči puščanje krvi iz drobnih krvnih žilic v telesu, ki zahteva nujno zdravniško pomoč.
English: The on-body injector is worn for 27 hours after placement and is programmed to make sure you do not receive Neulasta any sooner than 24 hours after your chemotherapy.
Slovenian: Injektor morate nositi 27 ur po namestitvi in je programiran tako, da zdravila Neulasta ne dobite prej kot 24 ur po kemoterapiji.
English: Due to the potential sensitivity of rapidly dividing myeloid cells to cytotoxic chemotherapy‚ pegfilgrastim should be administered at least 24 hours after administration of cytotoxic chemotherapy.
Slovenian: Zaradi možne občutljivosti hitro se delečih mieloidnih celic za citotoksično kemoterapijo je treba pegfilgrastim dati vsaj 24 ur po aplikaciji citotoksične kemoterapije.
English: B Properly dispose of the on-body injector.
Slovenian: B Pravilno zavrzite injektor.
English: What Neulasta looks like and contents of the pack
Slovenian: Izgled zdravila Neulasta in vsebina pakiranja
English: Clear, colourless solution for injection.
Slovenian: Bistra, brezbarvna raztopina za injiciranje.
English: Splenomegaly and splenic rupture
Slovenian: Splenomegalija in ruptura vranice
English: Neulasta may be exposed to room temperature (not above 30°C) for a maximum single period of up to 72 hours.
Slovenian: Zdravilo Neulasta sme biti izpostavljeno sobni temperaturi (ne nad 30 °C) za enkratno obdobje, ki ne sme preseči 72 ur.
English: The symptoms can include fever, abdominal pain, malaise, back pain and increased inflammatory markers.
Slovenian: Simptomi lahko vključujejo povišano telesno temperaturo, bolečine v trebuhu, slabo počutje, bolečine v hrbtu in povišane vrednosti vnetnih označevalcev.
English: • If you hear beeping, or when you check the status light and it is flashing red, contact your healthcare provider immediately.
Slovenian: • Če slišite piskanje, ali če lučka stanja rdeče utripa, ko jo preverite, se nemudoma posvetujte z zdravnikom.
English: These could be symptoms of a condition called “Capillary Leak Syndrome” which causes blood to leak from the small blood vessels into your body.
Slovenian: To so lahko simptomi motnje, imenovane "sindrom kapilarne prepustnosti", ki povzroči puščanje krvi iz drobnih krvnih žilic v telesu.
English: Reduction in the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes).
Slovenian: Skrajšanje trajanja nevtropenije in incidence febrilne nevtropenije pri odraslih bolnikih, zdravljenih s citotoksično kemoterapijo za maligne bolezni (z izjemo kronične mieloidne levkemije in mielodisplastičnih sindromov).
English: Do not recycle pre-filled syringes or throw them into household waste.
Slovenian: Napolnjenih injekcijskih brizg ne smete reciklirati ali jih zavreči med gospodinjske odpadke.
English: The pre-filled syringe (with or without blister wrapping) may also be provided with an automatic needle guard.
Slovenian: Napolnjena injekcijska brizga (v pretisnem omotu ali brez njega) je lahko na voljo z avtomatičnim ščitnikom igle.
English: A. MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE
Slovenian: A. IZDELOVALCI BIOLOŠKE UČINKOVINE IN IZDELOVALCI, ODGOVORNI ZA SPROŠČANJE SERIJ
English: Use a new pre-filled syringe and call your doctor or healthcare provider.
Slovenian: Uporabite novo napolnjeno injekcijsko brizgo in se posvetujte s svojim zdravnikom ali zdravstvenim delavcem.
English: Pack size of one.
Slovenian: Pakiranje po 1.
English: Granulocyte-colony stimulating factor can promote growth of myeloid cells in vitro and similar effects may be seen on some non-myeloid cells in vitro.
Slovenian: Granulocitne kolonije spodbujajoči faktor lahko spodbudi rast mieloičnih celic in vitro; podobni učinki bi se lahko pojavili pri nekaterih nemieloičnih celicah in vitro.
English: Avoid injecting into areas with scars or stretch marks.
Slovenian: Izognite se injiciranju v predele, kjer so brazgotine ali strije.
English: Consistent with the clinical effects and the potential for leukocytosis, a WBC count should be performed at regular intervals during therapy.
Slovenian: Zaradi kliničnih učinkov in zaradi možnosti levkocitoze je treba med zdravljenjem redno kontrolirati število belih krvničk.
English: If the status light is solid green or it has switched off, it is ok.
Slovenian: Če je lučka stanja stalno zelena ali se je izključila, je vse v redu.
English: The overall rate of febrile neutropenia was 9% of patients treated with pegfilgrastim and 18% of patients treated with filgrastim (difference 9%, 95% CI of -16.8%, -1.1%).
Slovenian: Celotna pogostost febrilne nevtropenije je bila pri bolnikih, zdravljenih s pegfilgrastimom, 9 %, pri bolnikih, zdravljenih s filgrastimom, pa 18 % (razlika 9 %, 95 % IZ je -16,8 %, -1,1 %).
English: If you have any concerns or further questions on the use of this medicine, contact your healthcare provider.
Slovenian: Če vas kaj skrbi ali imate dodatna vprašanja o uporabi tega zdravila, se posvetujte z zdravnikom.
English: • If the adhesive becomes saturated with fluid, or you see dripping, your medicine may have leaked out.
Slovenian: • Če je lepilo napojeno s tekočino, ali če opazite kapljanje, je zdravilo morda puščalo.
English: Medicine
Slovenian: zdravilo
English: How do I prepare my Neulasta injection?
Slovenian: Kako si pripravim injekcijo zdravila Neulasta?
English: Do not leave the pre-filled syringe exposed to direct sunlight.
Slovenian: Napolnjene injekcijske brizge ne puščajte izpostavljene neposredni sončni svetlobi.
English: The syringe for use with the on-body injector must either be used within 36 hours after it has reached room temperature (not above 30°C) or disposed of.
Slovenian: Brizgo za uporabo z injektorjem je treba ali uporabiti v 36 urah potem, ko doseže sobno temperaturo (ne nad 30 °C); v nasprotnem primeru jo je treba zavreči.
English: It is important to push down through the “snap” to deliver your full dose.
Slovenian: Pomembno je, da potisnete vse do "tleska", saj le tako injicirate celotni odmerek.
English: Clean the injection site with an alcohol wipe.
Slovenian: Mesto injiciranja očistite z alkoholnim zložencem.
English: Failure to keep the on-body injector at least this recommended distance may interfere with its operation and can lead to a missed or incomplete dose of Neulasta.
Slovenian: Če injektor ni odmaknjen za vsaj to priporočeno razdaljo, lahko pride do motenj v njegovem delovanju, to pa lahko povzroči, da ne dobite odmerka zdravila Neulasta, ali da ne dobite celotnega odmerka.
English: Reversible, mild to moderate elevations in uric acid and alkaline phosphatase, with no associated clinical effects, were uncommon; reversible, mild to moderate elevations in lactate dehydrogenase, with no associated clinical effects, were uncommon in patients receiving Neulasta following cytotoxic chemotherapy.
Slovenian: Reverzibilno, blago do zmerno zvišanje sečne kisline in alkalne fosfataze brez pridruženih kliničnih učinkov se je pojavilo občasno; reverzibilno, blago do zmerno zvišanje laktatne dehidrogenaze brez pridruženih kliničnih učinkov se je pojavilo občasno pri bolnikih, ki so dobivali zdravilo Neulasta po citotoksični kemoterapiji.
English: Permanently discontinue pegfilgrastim in patients with clinically significant hypersensitivity.
Slovenian: Dokončno prenehajte z zdravljenjem s pegfilgrastimom pri bolnikih s klinično signifikantno preobčutljivostjo.
English: See leaflet for further information.
Slovenian: Za nadaljne informacije glejte navodilo za uporabo.
English: If you have an allergic reaction during the delivery of Neulasta, remove the on-body injector by grabbing the edge of the adhesive pad and peeling off the on-body injector.
Slovenian: Če se vam med dajanjem zdravila Neulasta pojavi alergijska reakcija, odstranite injektor tako, da primete rob lepljive blazinice in injektor odlepite.
English: Then LIFT the syringe off skin.
Slovenian: Potem brizgo ODMAKNITE s kože.
English: Your healthcare provider will fill the on-body injector with Neulasta and then apply it directly to your skin using an adhesive pad.
Slovenian: Zdravnik bo injektor napolnil z zdravilom Neulasta in vam ga bo nato namestil neposredno na kožo z lepljivo blazinico.
English: Once a syringe has been removed from the refrigerator and has reached room temperature (not above 30°C) it must either be used within 3 days or disposed of.
Slovenian: Ko injekcijsko brizgo vzamete iz hladilnika in le-ta doseže sobno temperaturo (pod 30 °C), jo morate bodisi v 3 dneh porabiti ali pa zavreči.
English: Step 3: Inject A Hold the pinch.
Slovenian: 3. korak: Injiciranje A Držite kožno gubo.
English: Capillary leak syndrome has been reported after granulocyte-colony stimulating factor administration and is characterised by hypotension, hypoalbuminaemia, oedema and haemoconcentration.
Slovenian: Po uporabi granulocitne kolonije spodbujajočega faktorja so poročali o sindromu kapilarne prepustnosti, za katerega so značilni hipotenzija, hipoalbuminemija, edemi in hemokoncentracija.
English: Do not use any Neulasta that is left in the syringe.
Slovenian: Ne uporabljajte preostanka zdravila Neulasta, ki ostane v brizgi.
English: EU/1/02/227/001 - 1 pack EU/1/02/227/004 - 1 pack with needle guard EU/1/02/227/005 - 1 pack with on-body injector
Slovenian: EU/1/02/227/004 - pakiranje po 1 s ščitnikom igle EU/1/02/227/005 - pakiranje po 1 z injektorjem, ki se pritrdi na telo
English: Accidental exposure to freezing temperatures for a single period of less than 24 hours does not adversely affect the stability of Neulasta.
Slovenian: Če je zdravilo Neulasta pomotoma izpostavljeno temperaturam pod lediščem za enkratno obdobje, ki ne preseže 24 ur, to ne škoduje njegovi stabilnosti.
English: - Whilst wearing the Neulasta on body injector it is important that you keep the Alert Card provided by your doctor, pharmacist or nurse with you.
Slovenian: - Medtem ko imate nameščen injektor zdravila Neulasta, morate s seboj nositi opozorilno kartico za bolnika, ki vam jo je dal zdravnik, farmacevt ali medicinska sestra.
English: Musculoskeletal pain (myalgia, arthralgia, pain in extremity, back pain, musculoskeletal pain, neck pain)
Slovenian: Bolezni mišično-skeletneg a sistema in vezivnega tkiva bolečina v kosteh mišično-skeletna bolečina (mialgija, artralgija, bolečina v okončini, bolečina v hrbtu, mišično-skeletna bolečina, bolečina v vratu)
English: In a placebo-controlled, double blind study in patients with breast cancer the effect of pegfilgrastim on the incidence of febrile neutropenia was evaluated following administration of a chemotherapy regimen associated with a febrile neutropenia rate of 10-20% (docetaxel 100 mg/m every 3 weeks for
Slovenian: V dvojno slepi, s placebom kontrolirani študiji pri bolnicah z rakom na dojki so ocenili učinek pegfilgrastima na incidenco febrilne nevtropenije po uporabi takšne sheme kemoterapije, ki je povezana z 10-20 % deležem febrilne nevtropenije (docetaksel 100 mg/m vsake 3 tedne za 4 cikluse).
English: • if you have any of the following or combination of the following side effects: swelling or puffiness, which may be associated with passing water less frequently, difficulty breathing, abdominal swelling and feeling of fullness, and a general feeling of tiredness.
Slovenian: • se vam pojavi kateri od naslednjih neželenih učinkov ali kombinacija teh neželenih učinkov: oteklost ali zabuhlost, ki jo lahko spremlja manj pogostejše odvajanje urina, težko dihanje, oteklost trebuha in občutek polnosti ter splošen občutek utrujenosti.
English: It is important that you do not try to give yourself the injection unless you have received training from your doctor, nurse, or pharmacist.
Slovenian: Pomembno je, da si injekcije ne poskušate dati sami, če vas tega ne nauči zdravnik, medicinska sestra ali farmacevt.
English: Cases of capillary leak syndrome have been reported in the post-marketing setting with granulocytecolony stimulating factor use.
Slovenian: V obdobju trženja zdravila so poročali o primerih sindroma kapilarne prepustnosti med uporabo granulocitne kolonije spodbujajočega faktorja.
English: • After your on-body injector removal, place the on-body injector in a sharps disposal container whether the needle is exposed or not.
Slovenian: • Po odstranitvi injektorja injektor zavrzite v vsebnik za ostre odpadke, ne glede na to, ali je vidna gola igla ali ne.
English: (ng/ml)
Slovenian: pegfilgrastima (ng/ml)
English: There were no adverse effects observed in offspring from pregnant rats given pegfilgrastim subcutaneously, but in rabbits pegfilgrastim has been shown to cause embryo/foetal toxicity (embryo loss) at cumulative doses approximately 4 times the recommended human dose, which were not seen when pregnant rabbits were exposed to the recommended human dose.
Slovenian: Pri potomcih brejih podgan, ki so jim subkutano dali pegfilgrastim, niso opazili neželenih učinkov, pri kuncih pa so pokazali, da pegfilgrastim v kumulativnih odmerkih, ki so približno 4-krat višji od priporočenega odmerka za človeka, povzroča toksičnost za zarodek/plod (izgubo zarodka), česar pa niso videli, ko so breje kunčje samice izpostavili priporočenemu odmerku za človeka.
English: Sickle cell crisis2; Splenomegaly Splenic rupture2
Slovenian: srpastocelična kriza splenomegalija2, ruptura vranice
English: Single doses of 300 mcg/kg have been administered subcutaneously to a limited number of healthy volunteers and patients with non-small cell lung cancer without serious adverse reactions.
Slovenian: Omejeno število zdravih prostovoljcev in bolnikov z nedrobnoceličnim pljučnim rakom je prejelo subkutane posamične odmerke 300 µg/kg brez resnih neželenih reakcij.
English: The co-packed pre-filled syringe contains additional solution to compensate for residual liquid retained in the on-body injector after delivery.
Slovenian: V pakiranju priložena napolnjena injekcijska brizga vsebuje dodatno raztopino kot nadomestilo preostanka tekočine, ki ostane v injektorju po injiciranju.
English: Taking into account the PRAC Assessment Report on the PSUR(s) for pegfilgrastim, the scientific conclusions of the CHMP are as follows:
Slovenian: Upoštevajoč poročilo Odbora za oceno tveganja na področju farmakovigilance (PRAC) o oceni rednih posodobljenih poročil o varnosti zdravila (PSUR) za pegfilgrastim je Odbor za zdravila za uporabo v humani medicini (CHMP) sprejel naslednje znanstvene zaključke:
English: What if there is blood at my application site after the on-body injector has been removed?
Slovenian: Kaj če je po odstranitvi injektorja na mestu injiciranja kri?
English: In all cases, call your doctor or healthcare provider.
Slovenian: V vsakem od teh primerov se posvetujte s svojim zdravnikom ali zdravstvenim delavcem.
English: Capillary Leak Syndrome, which can be life-threatening if treatment is delayed, has been reported as uncommon (≥ 1/1,000 to < 1/100) in cancer patients undergoing chemotherapy following administration of granulocyte-colony stimulating factors; see section 4.4 and section “Description of selected adverse reactions” below.
Slovenian: Občasno (≥ 1/1.000 do < 1/100) so pri bolnikih z rakom, ki so prejemali kemoterapijo po uporabi granulocitne kolonije spodbujajočega faktorja, poročali o sindromu kapilarne prepustnosti, ki je lahko smrtno nevaren, če ni zdravljen takoj; glejte poglavje 4.4 in poglavje »Opis izbranih neželenih učinkov« spodaj.
English: * Produced in Escherichia coli cells by recombinant DNA technology followed by conjugation with polyethylene glycol (PEG).
Slovenian: *Pegfilgrastim izdelujejo s tehnologijo rekombinantne DNA v celicah Escherichia coli, kateri sledi konjugacija s polietilenglikolom (PEG).
English: ANNEX IV
Slovenian: PRILOGA IV
English: In an open-label, single dose study (n = 31) various stages of renal impairment, including end-stage renal disease, had no impact on the pharmacokinetics of pegfilgrastim.
Slovenian: Različne stopnje okvare ledvic, vključno s končno odpovedjo ledvic, v odprti študiji posamičnega odmerka (n = 31) niso vplivale na farmakokinetiko pegfilgrastima.
English: The youngest age group (0-5 years) had a higher mean exposure to pegfilgrastim (AUC) (± Standard Deviation) (47.9 ± 22.5 mcg·hr/mL) than older children aged 6-11 years and 12-21 years (22.0 ± 13.1 mcg·hr/mL and 29.3 ± 23.2 mcg·hr/mL, respectively) (see section 5.1).
Slovenian: V najmlajši starostni skupini (od 0 do 5 let) je bila povprečna izpostavljenost pegfilgrastimu (AUC) (± standardni odklon) večja (47,9 ± 22,5 µg·h/ml) kot med otroci, starimi od 6 do 11 (22,0 ± 13,1 µg·h/ml) in od 12 do 21 let (29,3 ± 23,2 µg·h/ml) (glejte poglavje 5.1).
English: Step 2: Monitor Dose Delivery
Slovenian: 2. korak: Nadzorujte injiciranje odmerka
English: Common (≥ 1/100 to < 1/10)
Slovenian: Pogosti (≥ 1/100 do
English: The needle cap of the pre-filled syringe contains dry natural rubber (a derivative of latex) (see section 4.4).
Slovenian: Pokrovček igle na napolnjeni injekcijski brizgi vsebuje suho naravno gumo (derivat lateksa) (glejte poglavje 4.4).
English: There are no or limited amount of data from the use of pegfilgrastim in pregnant women.
Slovenian: Podatkov o uporabi pegfilgrastima pri nosečnicah ni oziroma so omejeni.
English: The Neulasta pre-filled syringe for manual administration must not be used with the on-body injector.
Slovenian: Napolnjene injekcijske brizge zdravila Neulasta za ročno injiciranje se ne sme uporabljati z injektorjem.
English: If you have any problems, please ask your doctor or nurse for help and advice.
Slovenian: Če imate kakršne koli težave, se za pomoč in nasvet obrnite na zdravnika ali medicinsko sestro.
English: The incidence of febrile neutropenia was lower for patients randomised to receive pegfilgrastim compared with placebo (1% versus 17%, p < 0.001).
Slovenian: Incidenca febrilne nevtropenije je bila nižja pri bolnicah, ki so dobivale pegfilgrastim, kot pri tistih, ki so dobivale placebo (1 % v primerjavi s 17 %, p < 0,001).
English: • If the on-body injector at any time comes away from your skin before your full dose delivery, do not reapply it.
Slovenian: • Če se injektor kadar koli odlepi od kože, preden je bil injiciran celotni odmerek, ga ne nameščajte nazaj.
English: Important: read the package leaflet before handling pre-filled syringe.
Slovenian: Pomembno: Pred rokovanjem z napolnjeno injekcijsko brizgo preberite priloženo navodilo.
English: Neulasta is a clear, colourless solution for injection in a pre-filled syringe (6 mg/0.6 mL).
Slovenian: Zdravilo Neulasta je bistra, brezbarvna raztopina za injiciranje v napolnjeni injekcijski brizgi (6 mg/0,6 ml).
English: • the abdomen, except for the area around the navel.
Slovenian: • trebuh, razen predela okrog popka.
English: Over the entire study, the rate of febrile neutropenia was 13% of pegfilgrastim-treated patients compared with 20% of filgrastim-treated patients (difference 7%, 95% CI of -19%, 5%).
Slovenian: V celotni študiji je bila pogostost febrilne nevtropenije pri bolnikih, zdravljenih s pegfilgrastimom, 13 %, pri bolnikih, zdravljenih s filgrastimom, pa 20 % (razlika 7 %, 95 % IZ je -19 %, 5 %).
English: On-body injector becomes loose or falls off
Slovenian: Če se injektor zrahlja ali odpade
English: Insert the needle into the skin.
Slovenian: ZABODITE iglo v kožo.
English: Your doctor may decide that it would be more convenient for you to use Neulasta with the on-body injector.
Slovenian: Zdravnik bo morda presodil, da bi bila za vas bolj praktična uporaba zdravila Neulasta z injektorjem.
English: • allergic-type reactions, including redness and flushing, skin rash, and raised areas of the skin that itch.
Slovenian: • reakcije alergijske vrste, vključno s pordelostjo in zardevanjem, izpuščajem na koži in dvignjenimi predeli kože, ki srbijo.